Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Phase Ib : To determine the MTD and/or RP2D of buparlisib + carboplatin in patients with recurrent GBM who have progressed after SoC (RT with TMZ in combination and adjuvant) regardless of PI3K pathway activation status. same objective with buparlisib + lomustine phase II : To assess anti-tumor activity of buparlisib + carboplatin combination in patients with recurrent GBM who have progressed after SoC regardless of PI3K pathway activation status. To assess anti-tumor activity buparlisib + lomustine combination compared to lomustine + placebo in patients with recurrent GBM who have progressed after SoC regardless the PI3K pathway activation
Inclusion criteria
- recurrent glioblastoma multiform